Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.62 USD | +1.04% | +9.93% | +6.12% |
Financials (USD)
Sales 2024 * | 23.57M | Sales 2025 * | 20.72M | Capitalization | 79.54M |
---|---|---|---|---|---|
Net income 2024 * | -51M | Net income 2025 * | -66M | EV / Sales 2024 * | 0.73 x |
Net cash position 2024 * | 62.43M | Net cash position 2025 * | 135M | EV / Sales 2025 * | -2.67 x |
P/E ratio 2024 * |
-1.61
x | P/E ratio 2025 * |
-2.07
x | Employees | 109 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |
Latest transcript on Precision BioSciences, Inc.
1 day | +8.08% | ||
1 week | +7.88% | ||
Current month | +10.47% | ||
1 month | -18.56% | ||
3 months | +2.94% | ||
6 months | +11.76% | ||
Current year | +5.02% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Amoroso
CEO | Chief Executive Officer | 46 | 21-10-14 |
Jeff Smith
FOU | Founder | - | 06-01-25 |
John Kelly
DFI | Director of Finance/CFO | 57 | 20-10-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Buehler
CHM | Chairman | 66 | 19-11-07 |
Geno Germano
BRD | Director/Board Member | 63 | 20-03-09 |
Samuel Wadsworth
BRD | Director/Board Member | 75 | 21-11-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.16% | 2 M€ | -25.75% | ||
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 11.62 | +1.04% | 25 558 |
24-05-13 | 11.5 | +8.08% | 105,794 |
24-05-10 | 10.64 | -2.65% | 41,703 |
24-05-09 | 10.93 | -3.02% | 17,125 |
24-05-08 | 11.27 | +6.62% | 90,635 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
- Stock Market
- Equities
- DTIL Stock